66
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER

ANCA Associated Vasculitis Subtypes: Response [Response to Letter]

, ORCID Icon, , , & ORCID Icon
Pages 5687-5688 | Received 24 Aug 2022, Accepted 14 Sep 2022, Published online: 05 Oct 2022

References

  • Austin K, Janagan S, Wells M, et al. ANCA associated vasculitis subtypes: recent insights and future perspectives. J Inflamm Res. 2022;15:2567–2582.
  • Unizony S, Villarreal M, Miloslavsky EM, et al. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis. 2016;75(6):1166–1169.
  • Jayne DR, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021;384(7):599–609.